DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Copegus (Ribavirin) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (59)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Copegus (Ribavirin) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 59   Next >>

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: male

Reactions: Confusional State, Dyspnoea, Disorientation, Rash Pruritic, Loss of Consciousness, Burning Sensation, Malaise, Hypersomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-07-30

Copegus
    Indication: Hepatitis C
    End date: 2012-07-30

Telaprevir
    Indication: Hepatitis C
    End date: 2012-07-30



Possible Copegus side effects in male

Reported by a consumer/non-health professional from Chile on 2012-08-20

Patient: male, weighing 84.0 kg (184.8 pounds)

Reactions: Dyspnoea, Muscular Weakness, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-07-20
    End date: 2012-08-10

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-20



Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: male

Reactions: Dysgeusia, Dyspnoea, Coagulopathy, Anaemia, Pulmonary Thrombosis, Factor V Deficiency, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: zydus pharmaceutical
    Indication: Hepatitis C
    Start date: 2012-05-22

Pegasys
    Dosage: proclick autoinjector
    Indication: Hepatitis C
    Start date: 2012-05-22



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: female

Reactions: Asthma, Weight Increased, Dyspnoea, Fatigue, Dyspnoea Exertional, Nausea, Feeling Abnormal, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-05-25

Pegasys
    Indication: Hepatitis C
    Start date: 2012-03-09

Copegus
    Dosage: daily divided dose
    Indication: Hepatitis C
    Start date: 2012-03-09

Other drugs received by patient: Fluticasone Propionate; Ventolin



Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Scratch, White Blood Cell Count Decreased, Dyspnoea, Nausea, Drug Ineffective, Drug Hypersensitivity, Hyperhidrosis, Syncope, Middle Insomnia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Unevaluable Event, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
Victrelis
    Administration route: Oral

Copegus
    Administration route: Oral

Promethazine

Peginterferon Alfa-2A



Possible Copegus side effects in female

Reported by a physician from United States on 2012-08-09

Patient: female

Reactions: Dyspnoea, Injection Site Erythema, Rash Generalised, Anaphylactic Reaction, Blister

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C

Copegus
    Administration route: Oral
    Indication: Hepatitis C



Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 71.0 kg (156.2 pounds)

Reactions: Fatigue, Dyspnoea, Pancytopenia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: most recent dose:27/apr/2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Copegus
    Dosage: most recent dose:02/may/2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Telaprevir
    Dosage: most recent dose: 02/may/2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Other drugs received by patient: Demeclocycline HCL; Nadolol



Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Nerve Injury, Cystitis Radiation, Pain, Cyst, Fatigue, Emotional Disorder, Pain in JAW, Abdominal Pain Lower, Back Pain, Blood Urine Present, Dyspnoea, Musculoskeletal Discomfort, Joint Injury, Full Blood Count Decreased, Haemoglobin Decreased, Irritability, Syncope, Arthralgia, Insomnia

Drug(s) suspected as cause:
Copegus
    Administration route: Oral

Copegus
    Administration route: Oral

Pegasys

Victrelis



Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: male

Reactions: Fatigue, Dizziness, Blood Sodium Decreased, Decreased Appetite, Cough, White Blood Cell Count Decreased, Pneumonia, Dyspnoea, Haemoptysis, Nausea, Tuberculosis, Haemoglobin Decreased, Diarrhoea, Arthralgia, Sputum Discoloured, Asthenia, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16

Pegasys
    Indication: Hepatitis C
    Start date: 2012-03-16

Other drugs received by patient: Lisinopril



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Abdominal Pain, Thrombosis, Pruritus, Lymphadenopathy, Injection Site Haematoma, Hallucination, Auditory, Tooth Extraction, Headache, Appetite Disorder, Malaise, Menorrhagia, Skin Warm, Muscle Spasms, Blister, Crying, Back Pain, Stomatitis, Rash Erythematous, Insomnia, Swelling, Vision Blurred, Thyroid Disorder, Pain, Constipation, Fatigue, Chest Pain, Bone Disorder, Depression, Hallucination, Decreased Appetite, Blood Pressure Increased, Dyspnoea, Nausea, Musculoskeletal Pain, Rash, Anxiety, Gingival Pain, Psychotic Disorder, Lung Disorder, Oral Pain, Dysuria, Pollakiuria, Memory Impairment, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys

Telaprevir
    Indication: Hepatitis C

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C

Pegasys
    Dosage: dosage reported as one injection per week.
    Indication: Hepatitis C
    Start date: 2004-10-30
    End date: 2005-01-09

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2004-10-30
    End date: 2005-01-09

Other drugs received by patient: Wellbutrin; Prozac



Possible Copegus side effects in male

Reported by a physician from United States on 2012-07-26

Patient: male, weighing 71.0 kg (156.2 pounds)

Reactions: Dyspnoea, Fatigue, Pancytopenia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir
    Dosage: most recent dose on 02 may 2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Pegasys
    Dosage: most recent dose on 27 apr 2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Copegus
    Dosage: most recent dose on 02 may 2012
    Indication: Hepatitis C
    Start date: 2012-03-30

Other drugs received by patient: Nadolol; Demeclocycline HCL



Possible Copegus side effects in male

Reported by a physician from Canada on 2012-07-26

Patient: male

Reactions: Dyspnoea, Pericarditis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C

Blinded BI 201335 (Hcv Protease Inhibitor)
    Indication: Hepatitis C

Copegus
    Indication: Hepatitis C

Other drugs received by patient: Venlafaxine; Ranitidine; Meloxicam



Possible Copegus side effects in female

Reported by a physician from United States on 2012-07-25

Patient: female

Reactions: Eyelid Oedema, Renal Disorder, Dyspnoea, Hypersensitivity, Swelling Face, Rash Generalised, Anaemia, Abasia, Rash, Full Blood Count Decreased, Hospitalisation, Heart Rate Increased, Insomnia, Infusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-03

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-03

Incivek
    Indication: Hepatitis C
    End date: 2012-06-21

Other drugs received by patient: Flexeril; Levothyroxine Sodium



Possible Copegus side effects in male

Reported by a consumer/non-health professional from Italy on 2012-07-18

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Dyspnoea, Ventricular Hypokinesia, Cardiovascular Disorder, Arrhythmia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2010-11-05
    End date: 2011-04-13

Copegus
    Dosage: drug name reported as copegus.
    Indication: Hepatitis C
    Start date: 2010-11-05
    End date: 2011-04-13



Possible Copegus side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 164.0 kg (360.8 pounds)

Reactions: Dyspnoea, Dementia Alzheimer's Type, Swelling, Thyroid Disorder, Abdominal Distension, Blood Thyroid Stimulating Hormone Increased

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-16

Copegus
    Indication: Hepatitis C
    Start date: 2011-11-16



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-07-10

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Dyspnoea, Vomiting, Pneumonia, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Other drugs received by patient: Raltegravir; Citalopram Hydrobromide; Fortijuice; Acetaminophen; Metronidazole; Ciprofloxacin; Fortisip; SUN Bath Protective Tanning Lotion; Acyclovir; Truvada; Nystatin; Citalopram Hydrobromide



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-26

Patient: female

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Dyspnoea, Chest Discomfort, Haemoglobin Abnormal, Constipation, Abdominal Rigidity, Diarrhoea, Palpitations, RED Blood Cell Count Decreased, Asthenia, Cough, Lethargy

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-02-07

Copegus

Copegus
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-02-07



Possible Copegus side effects in male

Reported by a physician from United States on 2012-06-25

Patient: male

Reactions: Dyspnoea, Hypotension

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-11

Pegasys
    Dosage: dose reduced
    Start date: 2012-06-11

Copegus
    Dosage: dose reduced
    Administration route: Oral
    Start date: 2012-06-11

Daclatasvir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-11

Other drugs received by patient: Elavil; Amlodipine; Lorazepam; Efavirenz; Ibuprofen; Glucosamine Sulfate / Methyl Sulfonyl Methane; Procrit; Tenofovir Disoproxil Fumarate; Multi-Vitamin; Abacavir; Flomax; Prevacid; Loratadine; Flonase; Amoxicillin and Clavulanate Potassium; Lisinopril; Ketoconazole



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-06-15

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Pneumonia, Dyspnoea, Vomiting, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Other drugs received by patient: Truvada; Raltegravir; Acetaminophen; Citalopram Hydrobromide; Metronidazole; Fortijuice; Acyclovir; Ciproflaxacin; Citalopram Hydrobromide; SUN Bath Protective Tanning Lotion; Nystatin; Fortisip



Possible Copegus side effects in female

Reported by a physician from United States on 2012-06-14

Patient: female, weighing 72.7 kg (159.9 pounds)

Reactions: Mania, Abdominal Pain, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Administration route: Oral
    Indication: Depression
    Start date: 2012-04-19
    End date: 2012-04-21

Escitalopram Oxalate
    Administration route: Oral
    Start date: 2012-04-19
    End date: 2012-04-21

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-17

Escitalopram Oxalate
    End date: 2012-04-23

Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-18

Copegus
    Dosage: 600 mg in every morning and 400 mg in every evening
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-21



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-06-12

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Vomiting, Pneumonia, Dyspnoea, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

Other drugs received by patient: Acetaminophen; Citalopram; Truvada; Nystatin; Citalopram; Metronidazole; Raltegravir; Acyclovir; Ciprofloxacin; Fortisip



Possible Copegus side effects in 51 year old male

Reported by a consumer/non-health professional from Malaysia on 2012-06-08

Patient: 51 year old male

Reactions: Asthma, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2010-07-30
    End date: 2011-01-07

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-30
    End date: 2011-01-07



Possible Copegus side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04

Patient: 60 year old female

Reactions: Haemoglobin Decreased, Weight Increased, Dyspnoea, Oedema Peripheral, Tachycardia, Blood Thyroid Stimulating Hormone Increased, Bronchitis, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-04-01
    End date: 2011-07-01

Copegus
    Indication: Hepatitis C
    Start date: 2006-01-01
    End date: 2008-01-01

Victrelis
    Dosage: 800 mg;tid;
    Indication: Hepatitis C
    Start date: 2012-02-09

Pegasys
    Indication: Hepatitis C
    Start date: 2006-01-01
    End date: 2008-01-01

Pegasys
    Indication: Hepatitis C
    Start date: 2011-04-01
    End date: 2011-07-01

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-02

Other drugs received by patient: Cefpodoxime Proxetil; Bronchokod; Deturgylone



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-28

Patient: female

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Chest Discomfort, Dyspnoea, Haemoglobin Abnormal, Abdominal Rigidity, Palpitations, RED Blood Cell Count Decreased, Asthenia, Cough, Lethargy

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-02-07

Copegus
    Indication: Hepatitis C
    Start date: 2012-02-07

Copegus

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-02-07



Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-25

Patient: female, weighing 72.7 kg (159.9 pounds)

Reactions: Mania, Abdominal Pain, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Administration route: Oral
    Indication: Depression
    Start date: 2012-04-19
    End date: 2012-04-21

Copegus
    Dosage: 600 mg in every morning and 400 mg in every evening
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-21

Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-18

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-17

Escitalopram Oxalate
    End date: 2012-04-23



Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-22

Patient: female, weighing 72.7 kg (159.9 pounds)

Reactions: Abdominal Pain, Mania, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-18

Copegus
    Dosage: 600 mg in every morning and 400 mg in every evening
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-21

Escitalopram Oxalate
    End date: 2012-04-23

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2012-04-17

Escitalopram Oxalate
    Administration route: Oral
    Indication: Depression
    Start date: 2012-04-19
    End date: 2012-04-21



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: female

Reactions: Weight Decreased, Dyspnoea, PRE-Existing Condition Improved, Hypotension, Blood Count Abnormal, Dysgeusia, Eye Haemorrhage, Fatigue, Palpitations, Dehydration, Dizziness, Gingival Infection, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: in divided doses, route, form: not reported
    Indication: Hepatitis C
    Start date: 2011-11-11

Telaprevir
    Dosage: route: not reported
    Indication: Hepatitis C
    Start date: 2011-11-11
    End date: 2012-01-20

Copegus
    Dosage: divided doses, last injection on 20/apr/2012
    End date: 2012-04-20

Pegasys
    Dosage: route: not reported, last injection on 20/apr/2012
    Indication: Hepatitis C
    Start date: 2011-11-11
    End date: 2012-04-20



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-10

Patient: female

Reactions: White Blood Cell Count Decreased, Abdominal Pain, Chest Discomfort, Dyspnoea, Haemoglobin Abnormal, Abdominal Rigidity, RED Blood Cell Count Decreased, Palpitations, Cough, Lethargy

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-02-07

Copegus
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-02-07



Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-07

Patient: female

Reactions: Pneumonia, Dyspnoea, Disseminated Intravascular Coagulation, Anaemia, Pancytopenia, Abdominal Pain Upper, Fatigue, Mitral Valve Incompetence, Sepsis, Pleural Effusion, Cholecystitis, Hepatitis Toxic, Neutropenia, Blood Sodium Decreased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-02-11

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-02-11

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-02-11

Other drugs received by patient: Trazodone HCL



Possible Copegus side effects in 53 year old female

Reported by a physician from France on 2012-05-03

Patient: 53 year old female

Reactions: Chills, Respiratory Alkalosis, Blood Culture Positive, Proteus Test Positive, Dizziness, Electrocardiogram T Wave Inversion, Renal Failure Acute, Decreased Appetite, Pyelonephritis, Cough, Back Pain, Dyspnoea, Hyponatraemia, Cystitis, Escherichia Test Positive, Lung Disorder, Fungal Test Positive, Sepsis, Normochromic Normocytic Anaemia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-09-26
    End date: 2012-04-19

Victrelis
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-04-18

Copegus
    Dosage: 200 mg;tid
    Indication: Hepatitis C
    Start date: 2011-09-26
    End date: 2012-04-19

Other drugs received by patient: Truvada; Isentress; Neorecormon



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017